TABLE 1.
Rosacea and diet
| STUDY AUTHORS | YEAR | STUDY DESIGN | COUNTRY | PATIENT NUMBER (N) | FOLLOW-UP | DATA COLLECTED | OUTCOMES |
|---|---|---|---|---|---|---|---|
| Alcohol | |||||||
| Li et al4 | 2017 | Prospective Cohort | USA | 4,945 (out of, cohort of 82,737) | 14 years | Alcohol intake and incidence of rosacea |
|
| Caffeine | |||||||
| Li et al8 | 2018 | Prospective Cohort | USA | 4,945 (out of cohort of 82737) | 14 years | Caffeine intake and incidence of rosacea |
|
| Fatty Foods | |||||||
| Yuan et al16 | 2019 | Retrospective Case-Control | China | 2,637 | 2 years | Severity of rosacea (mild, mild to moderate, moderate and severe) |
|
| Omega-3 Fatty Acids | |||||||
| Bhargava et al36 | 2016 | Randomized controlled trial | India | 130 | 6 months | Subjective dry eye symptoms and in Meibomian gland score, Schirmer score and tear film break-up time (measures of eye dryness) after groups were randomized to receive either omega-3 fatty acids (capsules containing 180 mg eicosapentaenoic acid and 120 mg docosahexaenoic acid) or placebo twice daily |
|
| Zinc | |||||||
| Bamford et al54 | 2012 | Randomized double-blind trial | USA | 44 | 90 days | Improvement in rosacea zinc sulphate (220mg, 2 times a day) |
|
| Sharquie et al55 | 2006 | Double-blind, placebo-controlled study | Iraq | 25 | 6 months | Rosacea severity score after zinc sulphate (100mg, 3 times a day) |
|